Patient and Health Care Professional Perspectives: A Case Study of the Lung Cancer Integrated Care Pathway
Francesca Bravi(University of Ferrara), Tiziano Carradori(University of Ferrara), Antonio Frassoldati(Italian Oncology Group of Clinical Research), Eugenio Di Ruscio(University of Ferrara), Ulrich Wienand(Clinical Research Organization), Anna Ferrozzi(University of Ferrara), Giorgio Narciso Cavallesco(University of Ferrara), Giorgia Valpiani(University of Ferrara)
Cited by 13
Related Papers
Preoperative Chemotherapy Plus Trastuzumab, Lapatinib, or Both in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer: Results of the Randomized Phase II CHER-LOB Study
|Journal of Clinical Oncology|2012|368
Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results
|Annals of Oncology|2012|339
Adipose-Derived Mesenchymal Stem Cells as Stable Source of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Delivery for Cancer Therapy
|Cancer Research|2010|244
Association of Systemic Inflammation Index and Body Mass Index with Survival in Patients with Renal Cell Cancer Treated with Nivolumab
|Clinical Cancer Research|2019|240